Iqvia share price today

(IQV)

Iqvia share price is $197.27 & ₹16,763.22 as on 21 Dec 2024, 2.30 'hrs' IST

$197.27

▲

5.75

(3%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Iqvia share price in Dollar and Rupees. Guide to invest in Iqvia from India. Also see the sentimental analysis on Indian investors investing in Iqvia. Get details on the Indian mutual funds that are investing in Iqvia. Get Analyst recommendations and forecasts along with all the Iqvia's financials.

Iqvia share price movements

Today's Low: $191.62
Today's High: $200.14
$197.27
2.86%
Downside
Day's Volatility :4.26%
Upside
1.43%
52 Weeks Low: $187.62
52 Weeks High: $261.73
$197.27
4.89%
Downside
52 Weeks Volatility :28.32%
Upside
24.63%

Iqvia Returns

Period	Iqvia Holdings Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.05%	-11.1%	0.0%
6 Months	-7.86%	-6.0%	0.0%
1 Year	-14.61%	2.2%	0.0%
3 Years	-29.04%	-0.5%	-20.4%

Iqvia Key Statistics

in dollars & INR

Previous Close	$191.52
Open	$191.81
Today's High	$200.14
Today's Low	$191.62
Market Capitalization	$35.8B
Today's Volume	$3.2M
52 Week High	$261.73
52 Week Low	$187.62
Revenue TTM	$15.3B
EBITDA	$2.8B
Earnings Per Share (EPS)	$7.83
PE Ratio	25.19
Profit Margin	9.17%
Quarterly Earnings Growth YOY	-0.05%
Return On Equity TTM	22.0%

How to invest in Iqvia from India?

It is very easy for Indian residents to invest directly in Iqvia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iqvia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iqvia or IQV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iqvia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iqvia shares which would translate to 0.004 fractional shares of Iqvia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Iqvia, in just a few clicks!

Returns in Iqvia for Indian investors in Rupees

Investment Value

₹1,00,000

Iqvia investment value today

Current value as on today

₹1,16,809

Returns

₹16,809

(+16.81%)

Returns from Iqvia Stock

₹14,613 (false-14.61%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Iqvia

-4%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Iqvia on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -4% less investors are searching Iqvia in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Iqvia

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1488	-9.03	0.07%
Nippon India US Equity Opportunities Fund Direct Growth	18522	-6475.85	4.37%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	255	0.00	0.28%

Global Institutional Holdings in Iqvia

Vanguard Group Inc
11.03%
BlackRock Inc
8.39%
Harris Associates L.P.
5.61%
State Street Corp
4.28%
Geode Capital Management, LLC
2.26%
AllianceBernstein L.P.
2.14%

Analyst Recommendation on Iqvia

Buy

76%Buy

23%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Iqvia(by analysts ranked 0 to 5 stars)

Based on 26 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iqvia

What analysts predicted

Upside of 26.5%

Current:

$197.27

Target:

$249.54

Insights on Iqvia

Price Movement
In the last 7 days, IQV stock has moved down by -0.9%
Increasing Revenue
Iqvia Holdings Inc. has shown positive revenue growth over the last three quarters. Their revenue increased from $3.74 billion to $3.89 billion, reflecting an average growth of 2.0% per quarter.
Decreasing Net Profit
Iqvia Holdings Inc. has experienced a decline in net profit over the last two quarters. The net profit decreased from $363.0 million to $285.0 million, resulting in an average decrease of 21.5% per quarter.
IQV vs DHR (1 yr)
In the last 1 year, Iqvia Holdings Inc. has experienced a drawdown of -14.0%, however Danaher Corp. resisted the overall trend and outperformed by 13.2%
IQV vs A (3 yr)
In the last 3 years, Iqvia Holdings Inc. has experienced a drawdown of -28.7%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 0.2%
Price to Sales
Iqvia Holdings Inc. has a Price-to-Sales Ratio of 2.3, meaning that investors are willing to pay $2.3 for every $1 of sales the company makes. In comparison, Danaher Corp. has a much higher Price-to-Sales Ratio of 7.1, indicating that investors value its sales significantly more than those of Iqvia.

Iqvia Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.4B	↑ 6.91%
Net Income	$259.0M	↓ 80.21%
Net Profit Margin	2.49%	↓ 10.95%

	FY19	Y/Y Change
Revenue	$11.1B	↑ 6.49%
Net Income	$191.0M	↓ 26.25%
Net Profit Margin	1.72%	↓ 0.77%

	FY20	Y/Y Change
Revenue	$11.4B	↑ 2.44%
Net Income	$279.0M	↑ 46.07%
Net Profit Margin	2.46%	↑ 0.74%

	FY21	Y/Y Change
Revenue	$13.9B	↑ 22.14%
Net Income	$966.0M	↑ 246.24%
Net Profit Margin	6.96%	↑ 4.5%

	FY22	Y/Y Change
Revenue	$14.4B	↑ 3.86%
Net Income	$1.1B	↑ 12.94%
Net Profit Margin	7.57%	↑ 0.61%

	FY23	Y/Y Change
Revenue	$15.0B	↑ 3.98%
Net Income	$1.4B	↑ 24.47%
Net Profit Margin	9.06%	↑ 1.49%

	Q2 FY23	Q/Q Change
Revenue	$3.7B	↑ 2.08%
Net Income	$297.0M	↑ 2.77%
Net Profit Margin	7.97%	↑ 0.06%

	Q3 FY23	Q/Q Change
Revenue	$3.7B	↑ 0.21%
Net Income	$303.0M	↑ 2.02%
Net Profit Margin	8.11%	↑ 0.14%

	Q4 FY23	Q/Q Change
Revenue	$3.9B	↑ 4.63%
Net Income	$469.0M	↑ 54.79%
Net Profit Margin	12.0%	↑ 3.89%

	Q1 FY24	Q/Q Change
Revenue	$3.7B	↓ 4.32%
Net Income	$288.0M	↓ 38.59%
Net Profit Margin	7.7%	↓ 4.3%

	Q2 FY24	Q/Q Change
Revenue	$3.8B	↑ 1.98%
Net Income	$363.0M	↑ 26.04%
Net Profit Margin	9.52%	↑ 1.82%

	Q3 FY24	Q/Q Change
Revenue	$3.9B	↑ 2.15%
Net Income	$285.0M	↓ 21.49%
Net Profit Margin	7.32%	↓ 2.2%

	FY18	Y/Y Change
Profit	$3.7B	↑ 6.63%

	FY19	Y/Y Change
Profit	$3.8B	↑ 3.33%

	FY20	Y/Y Change
Profit	$3.9B	↑ 1.87%

	FY21	Y/Y Change
Profit	$4.6B	↑ 20.26%

	FY22	Y/Y Change
Profit	$5.0B	↑ 8.34%

	FY23	Y/Y Change
Profit	$5.2B	↑ 4.2%

	Q2 FY23	Q/Q Change
Profit	$1.3B	↑ 2.47%

	Q3 FY23	Q/Q Change
Profit	$1.3B	↑ 1.95%

	Q4 FY23	Q/Q Change
Profit	$1.1B	↓ 14.89%

	Q1 FY24	Q/Q Change
Profit	$1.0B	↓ 7.44%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↑ 2.42%

	Q3 FY24	Q/Q Change
Profit	$1.4B	↑ 30.37%

	FY18	Y/Y Change
Operating Cash Flow	$1.3B	↑ 29.28%
Investing Cash Flow	$-810.0M	↓ 31.93%
Financing Cash Flow	$-452.0M	↑ 527.78%

	FY19	Y/Y Change
Operating Cash Flow	$1.4B	↑ 13.0%
Investing Cash Flow	$-1.2B	↑ 46.91%
Financing Cash Flow	$-276.0M	↓ 38.94%

	FY20	Y/Y Change
Operating Cash Flow	$2.0B	↑ 38.25%
Investing Cash Flow	$-796.0M	↓ 33.11%
Financing Cash Flow	$-217.0M	↓ 21.38%

	FY21	Y/Y Change
Operating Cash Flow	$2.9B	↑ 50.18%
Investing Cash Flow	$-2.1B	↑ 164.2%
Financing Cash Flow	$-1.2B	↑ 469.12%

	FY22	Y/Y Change
Operating Cash Flow	$2.3B	↓ 23.18%
Investing Cash Flow	$-2.0B	↓ 4.61%
Financing Cash Flow	$-329.0M	↓ 73.36%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$402.0M	↓ 3.6%
Investing Cash Flow	$-596.0M	↑ 168.47%
Financing Cash Flow	$95.0M	↑ 9.2%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$583.0M	↑ 45.02%
Investing Cash Flow	$-1.4B	↑ 133.39%
Financing Cash Flow	$-144.0M	↓ 251.58%

Iqvia Technicals Summary

Sell

Neutral

Buy

Iqvia is currently in a neutral trading position according to technical analysis indicators.

Iqvia Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iqvia Holdings Inc.	-2.25%	-7.86%	-14.61%	-29.04%	27.52%
Idexx Laboratories, Inc.	-1.19%	-16.12%	-25.85%	-36.09%	56.6%
Agilent Technologies Inc.	0.5%	-0.42%	-3.79%	-14.76%	57.69%
Thermo Fisher Scientific, Inc.	2.1%	-7.4%	-1.07%	-19.46%	60.5%
Danaher Corp.	-3.09%	-10.99%	-1.23%	-28.75%	49.05%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iqvia Holdings Inc.	25.19	25.19	1.01	11.11	0.22	0.05	NA	38.37
Idexx Laboratories, Inc.	39.52	39.52	4.31	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.02	30.02	2.26	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.35	32.35	1.97	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	42.75	42.75	3.02	7.5	0.08	0.04	0.0	71.03

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iqvia Holdings Inc.	Buy	$35.8B	27.52%	25.19	9.17%
Idexx Laboratories, Inc.	Buy	$33.5B	56.6%	39.52	22.53%
Agilent Technologies Inc.	Buy	$38.4B	57.69%	30.02	21.75%
Thermo Fisher Scientific, Inc.	Buy	$197.6B	60.5%	32.35	14.48%
Danaher Corp.	Buy	$163.3B	49.05%	42.75	16.39%

About Iqvia

quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com

Organization	Iqvia
Employees	88000
CEO	Mr. Ari Bousbib
Industry	Health Services

Management People of Iqvia

Name	Title
Mr. Ari Bousbib	CEO & Chairman
Mr. Ronald E. Bruehlman	Executive VP & CFO
Mr. Eric M. Sherbet J.D.	Executive VP, General Counsel & Secretary
Mr. W. Richard Staub III	President of Research & Development Solutions
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Jim Berkshire	Executive Vice President of Global Technology & Operations
Dr. Jeffrey A. Spaeder M.D.	Senior VP, Global Chief Medical & Scientific Officer
Kerri Joseph	SVP of Investment Relation & Treasury
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP
Dr. Cynthia L. Verst	President of Design & Delivery Innovation

Important FAQs about investing in Iqvia from India :

What is Iqvia share price today?

Iqvia share price today stands at $197.27, Open: $191.81 ; Previous Close: $191.52 ; High: $200.14 ; Low: $191.62 ; 52 Week High: $261.73 ; 52 Week Low: $187.62. The stock opens at $191.81, after a previous close of $191.52. The stock reached a daily high of $200.14 and a low of $191.62, with a 52-week high of $261.73 and a 52-week low of $187.62.

Can Indians buy Iqvia shares?

Yes, Indians can invest in the Iqvia (IQV) from India.

With INDmoney, you can buy Iqvia at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iqvia at zero transaction cost.

How can I buy Iqvia shares from India?

It is very easy to buy Iqvia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iqvia be purchased?

Yes, you can buy fractional shares of Iqvia with INDmoney app.

What are the documents required to start investing in Iqvia stocks?

To start investing in Iqvia, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.